Compare · DNA vs LNZA

DNA vs LNZA

Side-by-side comparison of Ginkgo Bioworks Holdings Inc. (DNA) and LanzaTech Global Inc. (LNZA): market cap, price performance, sector, and recent activity on the wire.

Summary

  • DNA operates in Health Care, while LNZA operates in Industrials - the two are in different parts of the market.
  • DNA is the larger of the two at $483.6M, about 12.8x LNZA ($37.8M).
  • LNZA has been more active in the news (6 items in the past 4 weeks vs 5 for DNA).
  • DNA has more recent analyst coverage (18 ratings vs 5 for LNZA).
MetricDNALNZA
Company
Ginkgo Bioworks Holdings Inc.
LanzaTech Global Inc.
Price
-
-
Market cap
$483.6M
$37.8M
1M return
-
-
1Y return
-
-
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Chemicals
Exchange
NYSE
NASDAQ
IPO
2021
2021
News (4w)
5
6
Recent ratings
18
5
DNA

Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings, Inc. develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is based in Boston, Massachusetts.

Latest DNA

Latest LNZA